This story is heartbreaking to read. Faster turn around time for PAs is important but what we really need is appeals reform (electronic appeals submission, electronic tracking and faster review) #PAreform #insurance npr.org/sections/healt…

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. pubmed.ncbi.nlm.nih.gov/38492903/

With CVS mandated switching of Humira to Hyrimoz there are a few pt edu to ensure success 1) Hyrimoz has shown it is safe and effective 2) Hyrimoz pen is easier to use than Humira 3) commercial patients ($0 copay card) 4) may benefit US Healthcare system! #IBD #GITwitter

Entyvio subcutaneous injection is now FDA approved for Crohn's disease!! #IBD #GITwitter takeda.com/newsroom/newsr…

Join 🌟 faculty for ACG #IBD School & Eastern Régional PostGrad Course! 📌June 6-8, Washington DC 📲Register by May 7 for best rates gi.org Sara Horst MD, MPH, FACG Arun Swaminath MD & Isabel Roitman NP Atoosa Rabiee & Reezwana C, MD, FACG Simon Hong Jordan Axelrad, MD, MPH David Choi, PharmD & al!

Do health system specialty pharmacies provide better care compared to external specialty pharmacies (ESP)? 100%!! Here we have the time to initiation of Rinvoq for patients with IBD. ESP lead to further delays in therapy. #IBD #GITwitter David T. Rubin, MD track.smtpsendmail.com/9032119/c?p=9S…

📢 #IBD #Pharmacists: Sign up for our annual FREE (w/ CPE creds) virtual symposium with Crohn's & Colitis Foundation. We have a fantastic line-up of #pharmacists, keynote speaker Tauseef Ali MD, FACG AGAF FACP, and featured presentations on innovative services. 6/1/24@ 11AM-2PM EST: us06web.zoom.us/meeting/regist…

Super excited to talk about tips and trips for getting patients the IBD therapies they need! We have a success rate of >98% of getting patients initiated on therapy! 💊🩺 #IBD #Pharmacy #Healthcare

AIBD for the first time ever will have a pharmacist track as part of the national conference!! If you are a pharmacist practicing in IBD wanted to know which national IBD conference to attend, would highly recommend AIBD! Shubha Bhat, PharmD #AIBD #IBD #GItwitter #IBDpharmacy

Just finished our second IBD Pharmacist Virtual Symposium with a record 210 who registered! A great way to share best practices with IBD pharmacist and the new innovations happening across the country! Shubha Bhat, PharmD Thank you Crohn's & Colitis Foundation Crohn’s & Colitis Foundation IBD Pro for your support! #IBD

Excellent presentation from Jonathan Leighton about when to involve a colorectal surgeon!! 🩺 #IBD #surgery

Here is the live recording of our IBD Pharmacist Symposium with Crohn’s & Colitis Foundation IBD Pro Shubha Bhat, PharmD!! Please share with other IBD pharmacists! We especially had an innovations sections showing the great ways IBD pharmacists are improving care! #IBD #GITwitter crohnscolitisprofessional.org/programs/cme/i…

Skyrizi is officially approved for Ulcerative Colitis!! #gitwitter #IBD news.abbvie.com/2024-06-18-U-S…

ALERT: Pharmacies have been switching patients from Humira to Simlandi (interchangeable biosimilar) without proper notification to clinics. In some cases Humira was still covered by insurance, patients were switched without consent or patient education!! #IBD #GITwitter

Copay accumulators, maximizers, alternative funding plans 🚫 cause barriers for patient care leading to delays and treatment abandonment. Here is a primer to give a 101 on what these programs are and how to navigate them! #healthcare #insurance #GITwitter jmcp.org/doi/full/10.18…

Super excited for #AIBD 2024 and the support for a Pharmacy specific track!! This will help fill an important gap for training of IBD pharmacists. Miguel Regueiro Millie Long Corey Siegel Stephen B. Hanauer, MD Shubha Bhat, PharmD Jami Kinnucan, MD, FACG, AGAF, FCCF Bruce E. Sands #IBDPharmacistNetwork

Here is the complicated pathways patients need to navigate to getting access to the therapies they need. What used to be just challenges with access to therapy, it has now gotten out of hand with various different barriers to care! #IBD #GITwitter

Tremfya is now FDA approved for the treatment of moderately-to-severely active ulcerative colitis! #IBD #GITwitter prnewswire.com/news-releases/…